BPC-157 for Heart Health: What the Evidence Shows
What human and animal studies show about BPC-157 for heart health, how strong that evidence is, and what is still unproven.
- Strongest evidence
- Animal
- Human studies
- 3
- PubMed records, our ledger
- Animal studies
- 5
- PubMed records, our ledger
- Studies we summarised
- 1
- with an outcome for heart health
Evidence for heart health
Each row is an outcome related to heart health from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.
| Outcome | Result | Study type | Source |
|---|---|---|---|
| Myocardial infarction markers | BPC 157 reduced cardiac necrosis markers and attenuated gross, histological, ECG and echocardiographic damage in rats given isoprenaline. | Animal · rat (not a human result) | Biomedicines 2022, PMID 35203478 |
PubMed records for BPC-157 and heart health: 3 human, 5 animal (search counts, not studies we reviewed). Grades follow our .
How strong is it?
A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.
What heart disease means
MedlinePlus treats heart disease as an umbrella for many heart problems and names it the leading cause of death in the United States.[2]
What BPC-157 work comes closest to the heart
The ledger for BPC-157 plus cardiac terms counts 5 animal papers and no randomized human trial, so heart claims rest on animal models.
Calculated from pubmed query ("BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab] OR "pentadecapeptide BPC"[tiab]) AND (cardiovascular[tiab] OR cardiac[tiab] OR heart[tiab] OR myocard*[tiab] OR cardiomyopath*[tiab] OR atheroscler*[tiab] OR coronary[tiab] OR arrhythmi*[tiab]); date 2026-10-02; human filter count 9; human only count 3; animal filter count 5; randomized filter count 0. Formula: counts as recorded in the goals.json ledger (PubMed [tiab] query with the human, animal and RCT filters shown)
In rats given a drug that induces a heart attack, BPC-157 lowered the necrosis markers and kept left-ventricle pumping function on echocardiography.[1]
A human intravenous infusion study found no measurable effects on the tested biomarkers of the heart, liver, kidneys, thyroid or blood glucose.[3]
Other peptides people research for heart health
All peptides for heart health, comparedCommon questions
Does BPC-157 help with heart health?
The strongest study we summarise for heart health is animal evidence, across 1 study with an outcome for heart health. That is not proof it works in people.
Is BPC-157 approved for heart health?
No. BPC-157 is not FDA approved for any use, including heart health.
What is the best peptide for heart health?
There is no single answer. Our heart health overview compares each candidate by evidence grade and legal status rather than by popularity.
Is BPC-157 good for the heart?
Only a rat model of drug-induced heart attack reports a benefit; the human record is a tiny safety pilot with no efficacy test.[3]
Is BPC-157 safe for people with heart problems?
A systematic review of BPC-157 found no clinical safety data.[4]
More on BPC-157
Sources
- 1Stable Gastric Pentadecapeptide BPC 157 May Counteract Myocardial Infarction Induced by Isoprenaline in Rats.Biomedicines · 2022PMID 35203478Accessed 2 Oct 2026
- 2Official web pageOfficial web page · web page
- 3Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study.Alternative therapies in health and medicine · 2025PMID 40131143Accessed 2 Oct 2026
- 4Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.HSS journal : the musculoskeletal journal of Hospital for Special Surgery · 2025PMID 40756949Accessed 2 Oct 2026
Found an error? Report a correction.